Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check29 days agoChange DetectedThe page has been updated to version 2.16.0, and a specific clinical trial citation has been removed.SummaryDifference4%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.5%
Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.